Sun Pharmaceutical Industries Ltd
SUNPHARMASun Pharmaceutical Industries Ltd
SUNPHARMAPrice Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
38.18 | 6.16 | 0.89% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
43.14 | 6.21 | 0.54% |
Forecast & Ratings
Detailed Forecastfrom 35 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.
Investor Presentation
View olderPeers
Compare with peersCipla Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 29,145.28 | 32,201.59 | 27,328.22 | 30,091.40 | 33,489.09 | 34,357.31 | 39,729.96 | 44,394.10 | 49,851.04 | 49,851.04 | ||||||||||
Raw Materials | 6,724.15 | 8,402.37 | 7,193.98 | 8,302.08 | 8,929.60 | 9,328.30 | 10,459.15 | 11,349.07 | 35,968.04 | 35,968.04 | ||||||||||
Power & Fuel Cost | 545.44 | 525.09 | 559.97 | 613.60 | 621.89 | 627.09 | 702.78 | 830.05 | ||||||||||||
Employee Cost | 4,772.31 | 4,902.30 | 5,367.05 | 5,967.09 | 6,362.35 | 6,862.23 | 7,300.83 | 8,296.03 | ||||||||||||
Selling & Administrative Expenses | 5,219.20 | 5,224.61 | 4,727.00 | 5,350.33 | 6,995.37 | 6,283.41 | 7,366.88 | 9,482.36 | ||||||||||||
Operating & Other expenses | 3,752.78 | 2,434.80 | 3,983.83 | 3,739.60 | 3,214.78 | 6,235.53 | 7,147.91 | 2,326.73 | ||||||||||||
EBITDA | 8,131.40 | 10,712.42 | 5,496.39 | 6,118.70 | 7,365.10 | 5,020.75 | 6,752.41 | 12,109.86 | 13,883.00 | 13,883.00 | ||||||||||
Depreciation/Amortization | 1,037.53 | 1,264.75 | 1,499.84 | 1,753.25 | 2,052.78 | 2,079.95 | 2,143.74 | 2,529.43 | 2,556.64 | 2,556.64 | ||||||||||
PBIT | 7,093.87 | 9,447.67 | 3,996.55 | 4,365.45 | 5,312.32 | 2,940.80 | 4,608.67 | 9,580.43 | 11,326.36 | 11,326.36 | ||||||||||
Interest & Other Items | 523.24 | 399.80 | 517.57 | 555.25 | 302.73 | 141.43 | 127.35 | 172.00 | 238.47 | 238.47 | ||||||||||
PBT | 6,570.63 | 9,047.87 | 3,478.98 | 3,810.20 | 5,009.59 | 2,799.37 | 4,481.32 | 9,408.43 | 11,087.89 | 11,087.89 | ||||||||||
Taxes & Other Items | 2,024.92 | 2,083.50 | 1,383.28 | 1,144.78 | 1,244.66 | -104.45 | 1,208.59 | 934.85 | 1,511.51 | 1,511.51 | ||||||||||
Net Income | 4,545.71 | 6,964.37 | 2,095.70 | 2,665.42 | 3,764.93 | 2,903.82 | 3,272.73 | 8,473.58 | 9,576.38 | 9,576.38 | ||||||||||
EPS | 20.30 | 28.98 | 8.73 | 11.11 | 15.69 | 12.10 | 13.64 | 35.32 | 39.90 | 39.91 | ||||||||||
DPS | 1.00 | 3.50 | 2.00 | 2.75 | 4.00 | 7.50 | 10.00 | 11.50 | 13.50 | 12.50 | ||||||||||
Payout ratio | 0.05 | 0.12 | 0.23 | 0.25 | 0.25 | 0.62 | 0.73 | 0.33 | 0.34 | 0.31 |
Company Updates
Investor Presentation
Investor Presentation
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Sun Pharmaceutical Industries Ltd | 38.18 | 6.16 | 0.89% |
Cipla Ltd | 29.17 | 5.07 | 0.87% |
Zydus Lifesciences Ltd | 28.02 | 5.49 | 0.28% |
Dr Reddy's Laboratories Ltd | 19.02 | 4.56 | 0.63% |
Price Comparison
Compare SUNPHARMA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Sun Pharmaceutical Industries Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
ICICI Prudential Value Discovery Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6370% | Percentage of the fund’s portfolio invested in the stock 5.45% | Change in the portfolio weight of the stock over the last 3 months -0.66% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/90 (-2) |
ICICI Prudential Equity & Debt Fund - Direct Plan - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.4014% | Percentage of the fund’s portfolio invested in the stock 4.21% | Change in the portfolio weight of the stock over the last 3 months 0.40% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 6/174 (0) |
ICICI Prudential Bluechip Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3789% | Percentage of the fund’s portfolio invested in the stock 2.52% | Change in the portfolio weight of the stock over the last 3 months -0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 12/83 (0) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Sun Pharmaceutical Industries Ltd
Events
Dividend Trend
Increasing Dividends
SUNPHARMA has increased dividends consistently over the last 5 years
Dividend Yield
Current dividend yield is 0.89%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹8.86 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
Cash Dividend
Ex DateEx DateJul 12, 2024
Dividend/Share
₹5.00
Ex DateEx Date
Jul 12, 2024
Past Dividends
Cash Dividend
Ex DateEx DateFeb 9, 2024
Dividend/Share
₹8.50
Ex DateEx Date
Feb 9, 2024
Cash Dividend
Ex DateEx DateJul 28, 2023
Dividend/Share
₹4.00
Ex DateEx Date
Jul 28, 2023
Cash Dividend
Ex DateEx DateFeb 8, 2023
Dividend/Share
₹7.50
Ex DateEx Date
Feb 8, 2023
Cash Dividend
Ex DateEx DateAug 19, 2022
Dividend/Share
₹3.00
Ex DateEx Date
Aug 19, 2022
Cash Dividend
Ex DateEx DateFeb 9, 2022
Dividend/Share
₹7.00
Ex DateEx Date
Feb 9, 2022
News & Opinions
Buzzing stocks: Ambuja Cements, Satin Creditcare, AllcargoGati, Sun Pharma
1 week ago•Business Standard
Sun Pharma completes acquisition of Taro
1 week ago•Business Standard
Sun Pharma completes Taro merger, acquires all outstanding shares
1 week ago•Business Standard
Sun Pharma Completes Merger with Taro - News18
1 week ago•News18
Stocks to watch on June 24: Sun Pharma, Cipla, Lupin, Vedanta, Tata Steel
1 week ago•Business Standard
Top Stocks On D-Street: Sun Pharma, Hindustan Zinc, Bajaj Consumer Among 7 Stocks Lead Todays Market Focus
1 week ago•Zee News
Takeda Gives Sun Pharma, Cipla Rights to Commercialise Gastro Drug in India - News18
1 week ago•News18
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 10.62%, vs industry avg of 9%
Increasing Market Share
Over the last 5 years, market share increased from 13.58% to 13.81%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 29.15%, vs industry avg of 15.09%